Status:
COMPLETED
Mobile Technology for Blood Pressure Management
Lead Sponsor:
Stanford University
Collaborating Sponsors:
American Heart Association
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the mana...
Eligibility Criteria
Inclusion
- 18 years or older with an established diagnosis of essential hypertension
Exclusion
- Patients on more than 2 antihypertensives at time of enrollment
- Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
- Renal artery stenosis
- Primary hyperaldosteronism
- Cushing syndrome
- Coarctation of the aorta
- Drug-induced hypertension
- Pheochromocytoma
- Obstructive sleep apnea
- Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
- Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
- Prior diagnosis of heart failure or cardiomyopathy
- Stroke or transient ischemic attack within prior 6 months
- Prior organ transplantation
- Failure to obtain informed consent
- Pregnant or currently trying to become pregnant
- Patients who are enrolled in other research studies
Key Trial Info
Start Date :
March 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04841317
Start Date
March 31 2021
End Date
December 7 2021
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305